AI in Drug Screening and Drug Design
International Conference: 15-16 June 2026, Berlin, Germany
Innovative Tools, Platforms, and AI Solutions
The conference brings together researchers, technologists, and industry experts to explore the latest AI-driven approaches in drug screening and design. Participants will gain an overview of cutting-edge tools, practical applications, and emerging trends driving the next generation of AI-powered drug screening and design.
Keywords: virtual screening, in silico drug design, AI-driven tools, machine learning, deep learning, generative models, molecular docking, molecular modeling, predictive modeling, high-throughput screening, multi-target prediction, chemical libraries, cloud-based platforms, drug discovery
Interdisciplinary meetup: who should attend
- Researchers and chemists in AI-driven drug screening and design
- Computational and data scientists using machine learning for drug discovery
- Engineers and technologists building AI platforms and automated workflows
- R&D leads and product managers managing AI screening and design projects
- Industry partners providing tools and platforms
Topics
including but not limited to:
Advanced Tools and Platforms
Covers AI-enhanced docking tools, molecular modeling systems, automated workflows, and platforms for virtual screening of chemical libraries.
AI-Driven Virtual Screening and Drug Design
Focuses on AI methods for predicting compound activity, optimizing molecular properties, and designing new candidate molecules.
Case Studies and Practical Applications
Presents real-world examples of AI in drug discovery, including screening workflows, multi-target evaluation, and strategies for identifying promising compounds.
Future Perspectives
Explores emerging trends in AI for drug screening and design, including explainable and hybrid models, integration of diverse data sources, cloud-based high-throughput systems, automated end-to-end pipelines, collaborative data sharing, and feedback loops connecting computational predictions with experimental validation.
Connecting Industry and Academia
This conference goes beyond traditional discussions of computational drug discovery, serving as a hub for researchers and industry experts to share advances in AI-driven drug screening and design, including innovative approaches, emerging platforms, and practical tools.
By connecting participants across the value chain, the Conference fosters interdisciplinary exchange that drives technology transfer, commercialization, and real-world application of innovations.
